Although the operative mortality was lower, the long-term relative survival was poorer than that of the older patient.
However, percent mortality was lower on the refuge models than on the no refuge models (HNR=VNR>VWR).
However, 6 month mortality was lower in patients with higher admission BP (4% vs. 19.3%, p=0.002).
Mortality was lower in 1997 (11.8%) than in 1992 (18.5%), but the difference was not statistically significant.
In-hospital all-cause mortality was lower for blacks (23.0%), Hispanics (22.8%), and Asians (25.3%) than for white patients (27.6%).
However, 30 days mortality was lower in the hospital with higher nurse/patient ratio.
However, for patients with septic shock, mortality was lower, despite worse clinical presentation on admission.
Mortality was lower in patients receiving DE antibiotic (ATB) (22.9%, p: 0.095).
Conclusions: The incidence of infectious complications and mortality was lower in SVgroup.
All-cause mortality was lower in the BCV BIW (14%) and BCV QW groups (31%) relative to the placebo group (39%), but these differences were not statistically significant.
Cardiovascular mortality was lower for more vs less intensive therapy (3.48% vs 4.07%; RR, 0.84 [95% CI, 0.79 to 0.89]) but varied by baseline LDL-C level.
